NAV
17.74(0.02%)Fund Size (CR)
₹235.68Expense Ratio
0.47Scheme Type
Active FundValue Research
Min. investment
₹5,000Minimum Additional Investment
₹1,000Minimum SIP Investment
₹500Minimum Withdrawal
₹1,000Exit Load
0.5%Return Since Launch
16.34%
- 3M
- 6M
- 1Y
- 3Y
- All
Basic Details
Scheme Manager
Rohan Korde
Bench Mark
NIFTY Healthcare TRI
Type
OPEN
Lumpsum Returns
Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 14 August 2025 | 10060.95 | 0.61% | - | 1.66% | 750/908 |
1 Month | 22 July 2025 | 9942.34 | -0.58% | - | -0.56% | 411/898 |
3 Month | 22 May 2025 | 10327.76 | 3.28% | - | 3.90% | 443/868 |
6 Month | 21 February 2025 | 10997.24 | 9.97% | - | 12.81% | 641/840 |
1 Year | 22 August 2024 | 10324.03 | 3.24% | 3.24% | -0.17% | 224/725 |
3 Year | 22 August 2022 | 19216.86 | 92.17% | 24.30% | 20.02% | 107/480 |
5 Year | - | - | 0% | - | 22.48% | -/- |
Since Inception | 8 November 2021 | 17743.50 | 77.44% | 16.34% | 13.54% | 360/910 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 2 September 2024 | 1,20,000 | 122556.91 | 2.13% | 2.13% |
3 Year | 1 September 2022 | 3,60,000 | 500902.51 | 39.14% | 11.64% |
5 Year | - | - | - | - | - |
10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
- Investment type
- Scheme based
- SIP
- Lumpsum
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
4.39%
Standard Deviation
0.90%
Beta
1.18%
Sharpe Ratio
0.03%
Treynor's Ratio
2.30%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
---|---|---|---|---|---|
Sun Pharma.Inds. | 10.93% | 150888 | 25.75 | Equity | Pharmaceuticals |
Divi's Lab. | 8.68% | 31001 | 20.45 | Equity | Pharmaceuticals |
Max Healthcare | 6.12% | 115755 | 14.42 | Equity | Healthcare |
Apollo Hospitals | 5.66% | 17775 | 13.33 | Equity | Healthcare |
Cohance Life | 4.66% | 109972 | 10.98 | Equity | Pharmaceuticals |
Torrent Pharma. | 4.58% | 28861 | 10.80 | Equity | Pharmaceuticals |
Aurobindo Pharma | 3.66% | 75614 | 8.62 | Equity | Pharmaceuticals |
Fortis Health. | 3.51% | 96360 | 8.26 | Equity | Healthcare |
Lupin | 3.46% | 42213 | 8.14 | Equity | Pharmaceuticals |
Aster DM Health. | 3.19% | 124462 | 7.53 | Equity | Healthcare |
Peer Comparison
Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
---|---|---|---|---|---|---|---|
ITI Pharma and Healthcare Fund - Dir (G) | 235.68 | -0.58% | 3.28% | 9.97% | 3.24% | 24.30% | |
Nippon India Taiwan Equity Fund - Direct (G) | 351.43 | 9.17% | 23.59% | 20.10% | 29.89% | 25.43% | |
Nippon India Taiwan Equity Fund - Direct (IDCW) | 351.43 | 9.17% | 23.59% | 20.10% | 29.89% | 25.43% | |
Aditya Birla SL International Equity Fund - Direct (G) | 229.26 | 4.90% | 11.42% | 16.22% | 26.26% | 14.36% | |
Aditya Birla SL International Equity Fund - Direct (IDCW) | 229.26 | 4.90% | 11.42% | 16.22% | 26.26% | 14.36% | |
DSP Banking & Financial Services Fund - Dir (G) | 1346.44 | -2.42% | 1.62% | 14.69% | 18.79% | - |
List of Schemes under ITI Mutual Fund
News
ITI MF announces Income Distribution cum Capital Withdrawal (IDCW) under its scheme
ITI Mutual Fund has announced 26 August 2025 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) option under the following schemes. The amount of IDCW (Rs per unit) on the face value of Rs 10 per unit will be:ITI Balanced Advantage Fund:
Regular Plan ' IDCW: 0.02
Direct Plan ' IDCW: 0.02
Powered by Capital Market - Live News
ITI MF announces Income Distribution cum Capital Withdrawal (IDCW) under its scheme
ITI Mutual Fund has announced 10 July 2025 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) option under the following schemes. The amount of IDCW (Rs per unit) on the face value of Rs 10 per unit will be:ITI Balanced Advantage Fund:
Regular Plan ' IDCW: 0.10
Direct Plan ' IDCW: 0.10
Powered by Capital Market - Live News
ITI Mutual Fund announces change in scheme name
ITI Mutual Fund has announced change in scheme name under the following scheme, With effect from 30 June 2025.Change in the name of the Scheme:
Existing Scheme Name Revised Scheme Name ITI Focused Equity Fund ITI Focused Fund Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
18 October 2021
Total AUM (Cr)
₹235.68
ITI Pharma and Healthcare Fund - Dir (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, ITI Mutual Fund. Launched in 18 October 2021, this fund is managed by Rohan Korde. With assets under management (AUM) worth ₹235.68 (Cr), as of 22 August 2025, ITI Pharma and Healthcare Fund - Dir (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 16.34% since its launch.
The current NAV of ITI Pharma and Healthcare Fund - Dir (G) is ₹17.74, as on 22 August 2025. The fund's benchmark index is NIFTY Healthcare TRI. You can invest in ITI Pharma and Healthcare Fund - Dir (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹500 while the minimum lumpsum investment is ₹5,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
If redeemed/Switched out on or before 3 Months from the date of allotment Exit Load is 0.50% Exit Load after completion of 3 months - NIL The fund has generated 24.30% and undefined% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 98.71% in Equity, 1.29% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 66.75% in Pharmaceuticals & Biotech, 23.52% in Healthcare Services, 2.89% in Chemicals & Petrochemical, 2.40% in Fertilisers & Agrochemica, 1.29% in Cash & Others